Biodextris, Inc.
Biodextris is a leading Canadian CDMO specializing in biologics and vaccine development, with over 20 years of experience in high-value complex biologic products. Based in Laval, Quebec, it develops, manufactures, and tests a wide range of biologic products for vaccine, pharmaceutical, and other applications, supporting clients from pre-clinical to commercialization. The company emphasizes innovation, quality, and customer-centric approaches, and has recently expanded its facilities with significant investments supported by government programs. Biodextris aims to accelerate its growth and global presence through strategic partnerships and a project-based collaboration model.
Industries
Nr. of Employees
small (1-50)
Biodextris, Inc.
Products
Clinical and preclinical biologic materials
Development and manufacture of proteins, antibodies, enzymes and peptides suitable for preclinical and clinical studies, produced under cGMP or GLP conditions as required.
Nucleic-acid clinical batch production (plasmid and mRNA)
Process development and clinical-batch manufacturing support for plasmid DNA and mRNA-based therapeutics and vaccines, including downstream production and analytical characterization.
Clinical and preclinical biologic materials
Development and manufacture of proteins, antibodies, enzymes and peptides suitable for preclinical and clinical studies, produced under cGMP or GLP conditions as required.
Nucleic-acid clinical batch production (plasmid and mRNA)
Process development and clinical-batch manufacturing support for plasmid DNA and mRNA-based therapeutics and vaccines, including downstream production and analytical characterization.
Services
Analytical Services
Method development, validation, transfer, GMP QC testing and stability studies for biologics and small molecules using physicochemical, biophysical and immunological techniques.
Process and Development Services
Upstream and downstream process development, purification, formulation, cell-banking and process transfer to produce manufacturing-ready processes and support technical transfer to GMP operations.
cGMP Bioproduction and Fill–Finish Services
cGMP biomanufacturing of proteins, antibodies and nucleic-acid therapeutics for preclinical and clinical use, including segregated GMP suites, pilot-scale bioreactors, cell banking and aseptic fill–finish.
Facility and Analytical Infrastructure Services
Provision and operation of custom cGMP facilities with segregated manufacturing suites, controlled warehousing and analytical laboratories to support projects from preclinical development through clinical manufacturing.
Contract downstream manufacturing for plant-derived vaccines
Facility-based downstream manufacturing and clinical supply services for vaccines produced using plant-expression systems, including preparation of clinical material for early-phase trials.
Analytical Services
Method development, validation, transfer, GMP QC testing and stability studies for biologics and small molecules using physicochemical, biophysical and immunological techniques.
Process and Development Services
Upstream and downstream process development, purification, formulation, cell-banking and process transfer to produce manufacturing-ready processes and support technical transfer to GMP operations.
cGMP Bioproduction and Fill–Finish Services
cGMP biomanufacturing of proteins, antibodies and nucleic-acid therapeutics for preclinical and clinical use, including segregated GMP suites, pilot-scale bioreactors, cell banking and aseptic fill–finish.
Facility and Analytical Infrastructure Services
Provision and operation of custom cGMP facilities with segregated manufacturing suites, controlled warehousing and analytical laboratories to support projects from preclinical development through clinical manufacturing.
Contract downstream manufacturing for plant-derived vaccines
Facility-based downstream manufacturing and clinical supply services for vaccines produced using plant-expression systems, including preparation of clinical material for early-phase trials.
Expertise Areas
- Analytical method development and bioanalysis
- cGMP biomanufacturing for clinical materials
- Upstream and downstream process development and scale-up
- Cell line development and cell banking
Key Technologies
- High-performance liquid chromatography (HPLC/UPLC)
- High-resolution mass spectrometry
- Size-exclusion chromatography with multi-angle light scattering (SEC-MALS)
- Capillary isoelectric focusing (cIEF)